<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ryan VH</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>NIA NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><funding>National Institute on Aging</funding><pagination>RP104057</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12448747</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14</volume><pubmed_abstract>TDP-43 mislocalization and pathology occurs across a range of neurodegenerative diseases, but the pathways that modulate TDP-43 in neurons are not well understood. We generated a Halo-TDP-43 knock-in human induced pluripotent stem cell (iPSC) line and performed a genome-wide CRISPR interference FACS-based screen to identify modifiers of TDP-43 levels in neurons. A meta-analysis of our screen and publicly available screens identified both specific hits and pathways present across multiple screens, the latter likely responsible for generic protein level maintenance. We identified BORC, a complex required for anterograde lysosome transport, as a specific modifier of TDP-43 protein, but not mRNA, levels in neurons. BORC loss led to longer half-life of TDP-43 and other proteins, suggesting lyso</pubmed_abstract><journal>eLife</journal><pubmed_title>Maintenance of neuronal TDP-43 expression requires axonal lysosome transport.</pubmed_title><pmcid>PMC12448747</pmcid><funding_grant_id>Fi2GM142475</funding_grant_id><funding_grant_id>R01NS121608</funding_grant_id><funding_grant_id>R01 NS121608</funding_grant_id><funding_grant_id>Intramural Research Program</funding_grant_id><pubmed_authors>Maric D</pubmed_authors><pubmed_authors>Zou J</pubmed_authors><pubmed_authors>Johnson K</pubmed_authors><pubmed_authors>Ward ME</pubmed_authors><pubmed_authors>Hao L</pubmed_authors><pubmed_authors>Ramos DM</pubmed_authors><pubmed_authors>Yuan H</pubmed_authors><pubmed_authors>Johnson NL</pubmed_authors><pubmed_authors>Kampmann M</pubmed_authors><pubmed_authors>Qi YA</pubmed_authors><pubmed_authors>Replogle J</pubmed_authors><pubmed_authors>Lawton S</pubmed_authors><pubmed_authors>Frankenfield AM</pubmed_authors><pubmed_authors>Seddighi S</pubmed_authors><pubmed_authors>Faghri F</pubmed_authors><pubmed_authors>Ryan VH</pubmed_authors><pubmed_authors>Reyes JF</pubmed_authors><pubmed_authors>Epstein J</pubmed_authors><pubmed_authors>Nalls MA</pubmed_authors><pubmed_authors>Hawrot J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Maintenance of neuronal TDP-43 expression requires axonal lysosome transport.</name><description>TDP-43 mislocalization and pathology occurs across a range of neurodegenerative diseases, but the pathways that modulate TDP-43 in neurons are not well understood. We generated a Halo-TDP-43 knock-in human induced pluripotent stem cell (iPSC) line and performed a genome-wide CRISPR interference FACS-based screen to identify modifiers of TDP-43 levels in neurons. A meta-analysis of our screen and publicly available screens identified both specific hits and pathways present across multiple screens, the latter likely responsible for generic protein level maintenance. We identified BORC, a complex required for anterograde lysosome transport, as a specific modifier of TDP-43 protein, but not mRNA, levels in neurons. BORC loss led to longer half-life of TDP-43 and other proteins, suggesting lyso</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-03T14:39:25.737Z</modification><creation>2026-05-29T03:05:33.921Z</creation></dates><accession>S-EPMC12448747</accession><cross_references><pubmed>40970386</pubmed><doi>10.7554/eLife.104057</doi></cross_references></HashMap>